𝔖 Bobbio Scriptorium
✦   LIBER   ✦

News media coverage of human papillomavirus

✍ Scribed by Rebecca Anhang; Jo Ellen Stryker; Thomas C. Wright Jr.; Sue J. Goldie


Book ID
102107159
Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
81 KB
Volume
100
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

BACKGROUND

Now that human papillomavirus (HPV) DNA testing is being incorporated into cervical cancer screening programs, salient and accurate media information about HPV will be crucial to inform women's screening choices and to manage psychosocial responses to HPV DNA test results.

METHODS

The authors conducted a content analysis of 111 news stories about HPV from the 10 most circulated newspapers and from 3 major television networks for the period from January 1995 through July 2002. Stories were assessed for predominant theme (STD, cancer, or new tests); information about symptoms, transmission, prevention, and cancer‐causing properties of HPV; screening test descriptions; and recommended screening guidelines.

RESULTS

Thirty‐six percent of stories primarily were about new tests for HPV or cervical cancer, 30% of stories focused on cervical cancer or its link to HPV, and 27% of stories emphasized sexually transmitted diseases (STDs) or genital warts. Seventy‐nine percent of stories mentioned that HPV is an STD, and 50% of stories reported that HPV is very common. Twenty‐six percent of stories reported that most women with HPV will not develop cervical carcinoma. Of 81 stories that mentioned a screening test for HPV or cervical carcinoma, 38% reported the sensitivity of the test; 30% mentioned wrong, uncertain, or unnecessary test results; and 25% mentioned consequences of such results.

CONCLUSIONS

Media coverage of HPV could better fulfill women's educational needs by including information about low‐risk and high‐risk types of HPV and their differing links to cervical cancer; describing HPV prevention, transmission, and symptoms; explaining the benefits and consequences of HPV testing; and outlining the latest screening guidelines in every story. Cancer 2004;100:308–14. Β© 2003 American Cancer Society.


πŸ“œ SIMILAR VOLUMES


News coverage of biotechnology debates
✍ Susanna Hornig Priest; Toby Ten Eyck πŸ“‚ Article πŸ“… 2003 πŸ› Springer-Verlag 🌐 English βš– 605 KB
Integration of human papillomavirus vacc
✍ Schiffman, Mark πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 405 KB

There is justifiable excitement about the recent introduction of prophylactic vaccines against human papillomavirus (HPV) types 16 (HPV-16) and HPV-18. Preventing these infections theoretically could avert approximately 70% of cervical cancer cases worldwide. In the U.S., numerous influential advoca